Apple is preparing to introduce a display technology upgrade across its next wave of devices, with both the iPhone 18 lineup ...
Dealbreaker on MSN
Aktis has first biotech IPO of 2026, raising $318M to expand the reach of radiopharmaceuticals
Aktis Oncology’s IPO will support a pipeline of “miniprotein” radioconjugates that could offer advantages over other targeted ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback